1. Home
  2. Research
  3. Research Groups
  4. Infectious Diseases

Infectious Diseases

Search for publications

Only original articles, editorials, guidelines.

  • Vivancos-Gallego MJ, Sánchez-Conde M, Rodríguez-Domínguez M, Fernandez-Gonzalez P, Martínez-García L, Garcia-Mouronte E, Martínez-Sanz J, Moreno-Zamora AM, Casado JL, Ron R, Galán JC, Pérez-Elías MJ, Moreno S.

    Human Monkeypox in People With HIV: Transmission, Clinical Features, and Outcome

    Open forum infectious diseases . 9(11): . Number of citations: 10

    [doi:10.1093/ofid/ofac557]

  • Abad-Fernández M, Hernández-Walias FJ, Ruiz de León MJ, Vivancos MJ, Pérez-Elías MJ, Moreno A, Casado JL, Quereda C, Dronda F, Moreno S, Vallejo A.

    HTLV-2 Enhances CD8+ T Cell-Mediated HIV-1 Inhibition and Reduces HIV-1 Integrated Proviral Load in People Living with HIV-1

    VIRUSES-BASEL . 14(11): . Number of citations: 2

    [doi:10.3390/v14112472]

  • Santos Bravo M, Plault N, Sánchez-Palomino S, Rodríguez C, Navarro Gabriel M, Mosquera MM, Fernández Avilés F, Suarez-Lledó M, Rovira M, Bodro M, Moreno A, Linares L, Cofan F, Berengua C, Esteva C, Cordero E, Martin-Davila P, Aranzamendi M, Pérez Jiménez AB, Vidal E, Fernández Sabé N, Len O, Hantz S, Alain S, Marcos MÁ.

    Genotypic and Phenotypic Study of Antiviral Resistance Mutations in Refractory Cytomegalovirus Infection

    JOURNAL OF INFECTIOUS DISEASES . 226(9): 1528-1536. Number of citations: 4

    [doi:10.1093/infdis/jiac349]

  • Rosas M, Moreno S.

    Global strategy in the treatment of HIV infection in 2022.

    REVISTA ESPANOLA DE QUIMIOTERAPIA . 35 Suppl 3: 34-36. Number of citations: 1

    [doi:10.37201/req/s03.08.2022]

  • Ferrer R, Soriano A, Cantón R, Del Pozo JL, García-Vidal C, Garnacho-Montero J, Larrosa N, Rascado P, Salavert M, Pintado V, Giró-Perafita N, Badia X.

    A systematic literature review and expert consensus on risk factors associated to infection progression in adult patients with respiratory tract or rectal colonisation by carbapenem-resistant Gram-negative bacteria.

    REVISTA ESPANOLA DE QUIMIOTERAPIA . 35(5): 455-467. Number of citations: 3

    [doi:10.37201/req/062.2022]

  • Gómez-Pavón J, González Del Castillo J, Martín-Delgado MC, Martín Sánchez FJ, Martínez-Sellés M, Molero García JM, Moreno Guillén S, Rodríguez-Artalejo FJ, Ruiz-Galiana J, Cantón R, De Lucas Ramos P, García-Botella A, García-Lledó A, Hernández-Sampelayo T, Bouza E.

    COVID-19: Some unresolved issues.

    REVISTA ESPANOLA DE QUIMIOTERAPIA . 35(5): 421-434.

    [doi:10.37201/req/028.2022]

  • Pazdernik M, Iung B, Mutlu B, Alla F, Riezebos R, Kong W, Nunes MCP, Pierard L, Srdanovic I, Yamada H, De Martino A, Miglioranza MH, Magne J, Piper C, Laroche C, Maggioni AP, Lancellotti P, Habib G, Selton-Suty C.

    Surgery and outcome of infective endocarditis in octogenarians: prospective data from the ESC EORP EURO-ENDO registry.

    Infection . 50(5): 1191-1202.

    [doi:10.1007/s15010-022-01792-0]

  • González Del Castillo J, Martín-Delgado MC, Martín Sánchez FJ, Martínez-Sellés M, Molero García JM, Moreno Guillén S, Rodríguez-Artalejo FJ, Ruiz-Galiana J, Cantón R, De Lucas Ramos P, García-Botella A, García-Lledó A, Hernández-Sampelayo T, Gómez-Pavón J, Bouza E.

    Lessons from COVID-19 for future disasters: an opinion paper

    REVISTA ESPANOLA DE QUIMIOTERAPIA . 35(5): 444-454. Number of citations: 1

    [doi:10.37201/req/058.2022]

  • Gómez-Pavón J, González Del Castillo J, Martín-Delgado MC, Martín Sánchez FJ, Martínez-Sellés M, Molero García JM, MORENO GUILLÉN, SANTIAGO, Rodríguez Artalejo FJ, Ruiz-Galiana J, CANTÓN MORENO, RAFAEL.

    COVID-19: Some unresolved issues

    REVISTA ESPANOLA DE QUIMIOTERAPIA . 35(5): 421-434.

    [doi:10.37201/req/028.2022.]

  • Fortún J, Navas E.

    Latent tuberculosis infection: approach and therapeutic schemes

    REVISTA ESPANOLA DE QUIMIOTERAPIA . 35: 94-96. Number of citations: 3

    [doi:10.37201/req/s03.20.2022]

  • Meca-Lallana JE, Fernández-Prada M, García Vázquez E, Moreno Guillén S, Otero Romero S, Rus Hidalgo M, Villar Guimerans LM, Eichau Madueño S, Fernández Fernández Ó, Izquierdo Ayuso G, Álvarez Cermeño JC, Arnal García C, Arroyo González R, Brieva Ruiz L, Calles Hernández C, García Merino A, González Plata M, Hernández Pérez MÁ, Moral Torres E, Olascoaga Urtaza J, Oliva-Nacarino P, Oreja-Guevara C, Ortiz Castillo R, Oterino A, Prieto González JM, Ramió-Torrentá L, Rodríguez-Antigüedad A, Saiz A, Tintoré M, Montalbán Gairin X.

    Consensus statement on the use of alemtuzumab in daily clinical practice in Spain.

    Neurologia . 37(8): 615-630. Number of citations: 1

    [doi:10.1016/j.nrleng.2019.11.001]

  • Sánchez-Conde M, Vizcarra P, Pérez-García JM, Gion M, Martialay MP, Taboada J, Alonso-Fernández A, Sampayo-Cordero M, Malfettone A, Tena I, Torre S, Llombart-Cussac A, Cortés J.

    Pembrolizumab in combination with tocilizumab in high-risk hospitalized COVID-19 patients (COPERNICO): A randomized proof-of-concept phase II study.

    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES . 123: 97-103. Number of citations: 4

    [doi:10.1016/j.ijid.2022.08.007]

  • Espindola R, Vella V, Benito N, Mur I, Tedeschi S, Rossi N, Hendriks JGE, Sorlí L, Murillo O, Scarborough M, Scarborough C, Kluytmans J, Ferrari MC, Pletz MW, Mcnamara I, Escudero-Sanchez R, Arvieux C, Batailler C, Dauchy FA, Liu WY, Lora-Tamayo J, Praena J, Ustianowski A, Cinconze E, Pellegrini M, Bagnoli F, Rodríguez-Baño J, Del Toro MD.

    Preoperative and perioperative risk factors, and risk score development for prosthetic joint infection due to Staphylococcus aureus: a multinational matched case-control study

    CLINICAL MICROBIOLOGY AND INFECTION . 28(10): 1359-1366. Number of citations: 4

    [doi:10.1016/j.cmi.2022.05.010]

  • Meca-Lallana JE, Fernández-Prada M, García Vázquez E, Moreno Guillén S, Otero Romero S, Rus Hidalgo M, Villar Guimerans LM, Eichau Madueño S, Fernández Fernández Ó, Izquierdo Ayuso G, Álvarez Cermeño JC, Arnal García C, Arroyo González R, Brieva Ruiz L, Calles Hernández C, García Merino A, González Platas M, Hernández Pérez MÁ, Moral Torres E, Olascoaga Urtaza J, Oliva-Nacarino P, Oreja-Guevara C, Ortiz Castillo R, Oterino A, Prieto González JM, Ramió-Torrentá L, Rodríguez-Antigüedad A, Saiz A, Tintoré M, Montalbán Gairin X.

    Consensus statement on the use of alemtuzumab in daily clinical practice in Spain

    NEUROLOGIA . 37(8): 615-630. Number of citations: 2

    [doi:10.1016/j.nrl.2019.11.003]

  • Royo-Cebrecos C, Laporte-Amargós J, Peña M, Ruiz-Camps I, Puerta-Alcalde P, Abdala E, Oltolini C, Akova M, Montejo M, Mikulska M, Martín-Dávila P, Herrera F, Gasch O, Drgona L, Morales HMP, Brunel AS, García E, Isler B, Kern WV, Palacios-Baena ZR, de la Calle GM, Montero MM, Kanj SS, Sipahi OR, Calik S, Márquez-Gómez I, Marin JI, Gomes MZR, Hemmatti P, Araos R, Peghin M, Del Pozo JL, Yáñez L, Tilley R, Manzur A, Novo A, Carratalà J, Gudiol C.

    Pseudomonas aeruginosa Bloodstream Infections in Patients with Cancer: Differences between Patients with Hematological Malignancies and Solid Tumors.

    PATHOGENS . 11(10): .

    [doi:10.3390/pathogens11101132]

  • Torres-Fernandez D, Jiménez de Ory S, Fortuny C, Sainz T, Falcón D, Bernal E, Jiménez MC, Vilasaró MN, Epalza C, Navarro M, Ramos JT, Holguín Á, Prieto L.

    Integrase inhibitors in children and adolescents: clinical use and resistance

    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY . 77(10): 2784-2792. Number of citations: 1

    [doi:10.1093/jac/dkac259]

  • Madrid-Elena N, Serrano-Villar S, Gutiérrez C, Sastre B, Morín M, Luna L, Martín L, Santoyo-López J, López-Huertas MR, Moreno E, García-Bermejo ML, Moreno-Pelayo MÁ, Moreno S.

    Selective miRNA inhibition in CD8(+) cytotoxic T lymphocytes enhances HIV-1 specific cytotoxic responses.

    Frontiers in immunology . 13: 998368-998368.

    [doi:10.3389/fimmu.2022.998368]

  • Vallejo A, Vizcarra P, Martín-Hondarza A, Gómez-Maldonado S, Haemmerle J, Velasco H, Casado JL.

    Impact of SARS-CoV-2-specific memory B cells on the immune response after mRNA-based Comirnaty vaccine in seronegative health care workers

    FRONTIERS IN MICROBIOLOGY . 13: 1002748-1002748.

    [doi:10.3389/fmicb.2022.1002748]